Coronation Fund Managers Ltd. Novo Nordisk A S Transaction History

Coronation Fund Managers Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$102.11 - $135.92 $9.27 Million - $12.3 Million	-90,800 Reduced 78.76%	24,494 $3.15 Million
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $1.75 Million - $2.1 Million	19,910 Added 20.87%	115,294 $11.9 Million
Q3 2023 Oct 18, 2023	BUY	$90.94 - $199.54 $3.38 Million - $7.42 Million	37,176 Added 63.87%	95,384 $8.67 Million
Q2 2023 Jul 27, 2023	BUY	$155.98 - $172.65 $9.08 Million - $10 Million	58,208 New	58,208 $9.42 Million

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Coronation Fund Managers Ltd., based on Form 13F filings with the SEC.

Stay updated on Coronation Fund Managers Ltd. with notifications on news.